<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Tradit Complement Med</journal-id><journal-id journal-id-type="iso-abbrev">J Tradit Complement Med</journal-id><journal-title-group><journal-title>Journal of Traditional and Complementary Medicine</journal-title></journal-title-group><issn pub-type="epub">2225-4110</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26870676</article-id><article-id pub-id-type="pmc">4738038</article-id><article-id pub-id-type="publisher-id">S2225-4110(14)00045-5</article-id><article-id pub-id-type="doi">10.1016/j.jtcme.2014.11.031</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Exploratory studies on the therapeutic effects of <italic>Kumarabharana Rasa</italic> in the management of chronic tonsillitis among children at a tertiary care hospital of Karnataka</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Arun Raj</surname><given-names>G.R.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Shailaja</surname><given-names>U.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Debnath</surname><given-names>Parikshit</given-names></name><email>docdebnath84@gmail.com</email><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">∗</xref></contrib><contrib contrib-type="author"><name><surname>Banerjee</surname><given-names>Subhadip</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Prasanna N.</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Kaumarabhritya, SDM College of Ayurveda and Hospital, Hassan, Karnataka, India</aff><aff id="aff2"><label>b</label>Department of Swasthavritta, SDM College of Ayurveda and Hospital, Hassan, Karnataka, India</aff><aff id="aff3"><label>c</label>Department of Pharmacology, Bengal Institute of Pharmaceutical Sciences, Kalyani, West Bengal, India</aff><aff id="aff4"><label>d</label>Department of Shalyatantra, SDM College of Ayurveda and Hospital, Hassan, Karnataka, India</aff><author-notes><corresp id="cor1"><label>∗</label>Corresponding author. SDM College of Ayurveda and Hospital, Hassan 573 201, Karnataka, India. <email>docdebnath84@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>16</day><month>1</month><year>2015</year></pub-date><volume>6</volume><issue>1</issue><fpage>29</fpage><lpage>33</lpage><history><date date-type="received"><day>3</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>19</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. All rights reserved.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Center for Food and Biomolecules, National Taiwan University</copyright-holder><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions><abstract><p><offsets xml_i="3958" xml_f="4016" txt_i="11" txt_f="69">The effect of an Ayurvedic poly-herbo-mineral formulation </offsets><italic><offsets xml_i="4024" xml_f="4042" txt_i="69" txt_f="87">Kumarabharana Rasa</offsets></italic><offsets xml_i="4051" xml_f="4099" txt_i="87" txt_f="135"> (KR) in the management of chronic tonsillitis (</offsets><italic><offsets xml_i="4107" xml_f="4116" txt_i="135" txt_f="144">Tundikeri</offsets></italic><offsets xml_i="4125" xml_f="4399" txt_i="144" txt_f="418">) in children has been assessed in this study. This clinical study was a double-arm study with a pre- and post-test design at the outpatient level in a tertiary Ayurveda hospital attached to a teaching institute located in district headquarters in Southern India. Patients (</offsets><italic><offsets xml_i="4407" xml_f="4408" txt_i="418" txt_f="419">n</offsets></italic><offsets xml_i="4417" xml_f="4663" txt_i="419" txt_f="665"> = 40) with chronic tonsillitis satisfying diagnostic criteria and aged between 5 and 10 years were selected from the outpatient Department of Kaumarbhritya, SDM College of Ayurveda and Hospital, Hassan. Among them, 20 patients were treated with </offsets><italic><offsets xml_i="4671" xml_f="4689" txt_i="665" txt_f="683">Kumarabharana rasa</offsets></italic><offsets xml_i="4698" xml_f="4807" txt_i="683" txt_f="792"> (tablet form) at a dose of 500 mg once daily for 30 days (Group A). The other 20 patients were treated with </offsets><italic><offsets xml_i="4815" xml_f="4827" txt_i="792" txt_f="804">Godhuma Vati</offsets></italic><offsets xml_i="4836" xml_f="4917" txt_i="804" txt_f="885"> (placebo) at a dose of 500 mg once daily for 30 days (Group B). In both groups, </offsets><italic><offsets xml_i="4925" xml_f="4930" txt_i="885" txt_f="890">Madhu</offsets></italic><offsets xml_i="4939" xml_f="4948" txt_i="890" txt_f="899"> was the </offsets><italic><offsets xml_i="4956" xml_f="4963" txt_i="899" txt_f="906">Anupana</offsets></italic><offsets xml_i="4972" xml_f="5159" txt_i="906" txt_f="1093"> advised. After completion of 30 days of treatment, the patients were assessed on the following day and another investigation took place 15 days later. Statistically significant effects (</offsets><italic><offsets xml_i="5167" xml_f="5168" txt_i="1093" txt_f="1094">p</offsets></italic><offsets xml_i="5177" xml_f="5317" txt_i="1094" txt_f="1231"> &lt; 0.05) in the reduction of all signs and symptoms of chronic tonsillitis after KR treatment were observed. These results indicate that </offsets><italic><offsets xml_i="5325" xml_f="5343" txt_i="1231" txt_f="1249">Kumarabharana Rasa</offsets></italic><offsets xml_i="5352" xml_f="5438" txt_i="1249" txt_f="1335"> has an ameliorative effect in reducing the signs and symptoms of chronic tonsillitis.</offsets></p></abstract><abstract abstract-type="graphical"><title><offsets xml_i="5496" xml_f="5514" txt_i="1347" txt_f="1365">Graphical abstract</offsets></title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"></graphic></fig></abstract><kwd-group><title>Keywords</title><kwd><italic>Kumarabharana Rasa</italic></kwd><kwd>children</kwd><kwd>chronic tonsillitis</kwd><kwd><italic>Tundikeri</italic></kwd><kwd>polyherbomineral formulation</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label><offsets xml_i="5879" xml_f="5880" txt_i="1373" txt_f="1374">1</offsets></label><title><offsets xml_i="5895" xml_f="5907" txt_i="1374" txt_f="1386">Introduction</offsets></title><p><offsets xml_i="5918" xml_f="5995" txt_i="1387" txt_f="1464">Chronic tonsillitis (CHT) is one of the most common otolaryngologic diseases.</offsets><xref rid="bib1" ref-type="bibr"><sup><offsets xml_i="6033" xml_f="6034" txt_i="1464" txt_f="1465">1</offsets></sup></xref><offsets xml_i="6047" xml_f="6303" txt_i="1465" txt_f="1721"> CHT is rare in infants and older people. In young children, tonsillitis is one of the recurrent upper respiratory tract infections. CHT is a highly prevalent disease in the pediatric age group, and it peaks between 3 and 10 years of age and then declines.</offsets><xref rid="bib2" ref-type="bibr"><offsets xml_i="6336" xml_f="6337" txt_i="1721" txt_f="1722">2</offsets></xref><offsets xml_i="6344" xml_f="6346" txt_i="1722" txt_f="1724">, </offsets><xref rid="bib3" ref-type="bibr"><offsets xml_i="6379" xml_f="6380" txt_i="1724" txt_f="1725">3</offsets></xref><offsets xml_i="6387" xml_f="6464" txt_i="1725" txt_f="1802"> In general practice children frequently visit with recurrent throat problems</offsets><xref rid="bib4" ref-type="bibr"><sup><offsets xml_i="6502" xml_f="6503" txt_i="1802" txt_f="1803">4</offsets></sup></xref><offsets xml_i="6516" xml_f="6607" txt_i="1803" txt_f="1894"> and the incidence of this disease accounts for about 7% of all visits to the pediatrician.</offsets><xref rid="bib3" ref-type="bibr"><sup><offsets xml_i="6645" xml_f="6646" txt_i="1894" txt_f="1895">3</offsets></sup></xref><offsets xml_i="6659" xml_f="6793" txt_i="1895" txt_f="2029"> Children with CHT experience discomfort, and the disease also impacts on social, emotional, and financial aspects for family members.</offsets><xref rid="bib5" ref-type="bibr"><sup><offsets xml_i="6831" xml_f="6832" txt_i="2029" txt_f="2030">5</offsets></sup></xref><offsets xml_i="6845" xml_f="6888" txt_i="2030" txt_f="2073"> Tonsilitis is an infection of the tonsils.</offsets><xref rid="bib6" ref-type="bibr"><offsets xml_i="6921" xml_f="6922" txt_i="2073" txt_f="2074">6</offsets></xref><offsets xml_i="6929" xml_f="6931" txt_i="2074" txt_f="2076">, </offsets><xref rid="bib7" ref-type="bibr"><offsets xml_i="6964" xml_f="6965" txt_i="2076" txt_f="2077">7</offsets></xref><offsets xml_i="6972" xml_f="6974" txt_i="2077" txt_f="2079">, </offsets><xref rid="bib8" ref-type="bibr"><offsets xml_i="7007" xml_f="7008" txt_i="2079" txt_f="2080">8</offsets></xref><offsets xml_i="7015" xml_f="7268" txt_i="2080" txt_f="2333"> Despite its high prevalence, the etiology of CHT has remained indistinct. The surface and deep bacterial flora of chronic inflamed tonsils consist of an abundance of probable pathogenic aerobic and anaerobic bacteria, primarily of streptococcal origin.</offsets><xref rid="bib9" ref-type="bibr"><offsets xml_i="7301" xml_f="7302" txt_i="2333" txt_f="2334">9</offsets></xref><offsets xml_i="7309" xml_f="7311" txt_i="2334" txt_f="2336">, </offsets><xref rid="bib10" ref-type="bibr"><offsets xml_i="7345" xml_f="7347" txt_i="2336" txt_f="2338">10</offsets></xref><offsets xml_i="7354" xml_f="7356" txt_i="2338" txt_f="2340">, </offsets><xref rid="bib11" ref-type="bibr"><offsets xml_i="7390" xml_f="7392" txt_i="2340" txt_f="2342">11</offsets></xref><offsets xml_i="7399" xml_f="7401" txt_i="2342" txt_f="2344">, </offsets><xref rid="bib12" ref-type="bibr"><offsets xml_i="7435" xml_f="7437" txt_i="2344" txt_f="2346">12</offsets></xref><offsets xml_i="7444" xml_f="7446" txt_i="2346" txt_f="2348">, </offsets><xref rid="bib13" ref-type="bibr"><offsets xml_i="7480" xml_f="7482" txt_i="2348" txt_f="2350">13</offsets></xref><offsets xml_i="7489" xml_f="7686" txt_i="2350" txt_f="2547"> Tonsils are part of the immune system. Therefore, due to the decrease in immunity and the tonsils' incompetence in helping the immune system, they actually become a source of recurrent infections.</offsets><xref rid="bib3" ref-type="bibr"><sup><offsets xml_i="7724" xml_f="7725" txt_i="2547" txt_f="2548">3</offsets></sup></xref><offsets xml_i="7738" xml_f="8011" txt_i="2548" txt_f="2821"> The current treatment option for CHT is tonsillectomy, but it is not the ultimate solution. The generally accepted criteria for tonsillectomy are at least three to seven episodes of tonsillitis per year in spite of medical therapy, but there is no international consensus.</offsets><xref rid="bib14" ref-type="bibr"><sup><offsets xml_i="8050" xml_f="8052" txt_i="2821" txt_f="2823">14</offsets></sup></xref></p><p><offsets xml_i="8072" xml_f="8127" txt_i="2824" txt_f="2879">In Ayurvedic thought, tonsillitis can be correlated to </offsets><italic><offsets xml_i="8135" xml_f="8144" txt_i="2879" txt_f="2888">Tundikeri</offsets></italic><offsets xml_i="8153" xml_f="8175" txt_i="2888" txt_f="2910">, which is one of the </offsets><italic><offsets xml_i="8183" xml_f="8203" txt_i="2910" txt_f="2930">Urdhvajatrugata Roga</offsets></italic><offsets xml_i="8212" xml_f="8265" txt_i="2930" txt_f="2983"> (diseases of the head and neck); it is mentioned in </offsets><italic><offsets xml_i="8273" xml_f="8286" txt_i="2983" txt_f="2996">Talugata Roga</offsets></italic><xref rid="bib15" ref-type="bibr"><sup><offsets xml_i="8334" xml_f="8336" txt_i="2996" txt_f="2998">15</offsets></sup></xref><offsets xml_i="8349" xml_f="8386" txt_i="2998" txt_f="3035"> (diseases of the palate) as well as </offsets><italic><offsets xml_i="8394" xml_f="8409" txt_i="3035" txt_f="3050">Kanthagata Roga</offsets></italic><offsets xml_i="8418" xml_f="8444" txt_i="3050" txt_f="3076"> (diseases of the throat).</offsets><xref rid="bib16" ref-type="bibr"><sup><offsets xml_i="8483" xml_f="8485" txt_i="3076" txt_f="3078">16</offsets></sup></xref><offsets xml_i="8498" xml_f="8569" txt_i="3078" txt_f="3149"> Ayurveda explains that it is caused by the vitiation and imbalance of </offsets><italic><offsets xml_i="8577" xml_f="8583" txt_i="3149" txt_f="3155">Doshas</offsets></italic><offsets xml_i="8592" xml_f="8616" txt_i="3155" txt_f="3179"> (bodily humors), i.e., </offsets><italic><offsets xml_i="8624" xml_f="8635" txt_i="3179" txt_f="3190">Vata, Pitta</offsets></italic><offsets xml_i="8644" xml_f="8650" txt_i="3190" txt_f="3196">, and </offsets><italic><offsets xml_i="8658" xml_f="8663" txt_i="3196" txt_f="3201">Kapha</offsets></italic><offsets xml_i="8672" xml_f="8696" txt_i="3201" txt_f="3225">. Mainly derangement of </offsets><italic><offsets xml_i="8704" xml_f="8709" txt_i="3225" txt_f="3230">Kapha</offsets></italic><offsets xml_i="8718" xml_f="8723" txt_i="3230" txt_f="3235"> and </offsets><italic><offsets xml_i="8731" xml_f="8736" txt_i="3235" txt_f="3240">Rakta</offsets></italic><offsets xml_i="8745" xml_f="8798" txt_i="3240" txt_f="3293"> (blood) is preceded by impaired digestive capacity (</offsets><italic><offsets xml_i="8806" xml_f="8814" txt_i="3293" txt_f="3301">Mandagni</offsets></italic><offsets xml_i="8823" xml_f="8824" txt_i="3301" txt_f="3302">/</offsets><italic><offsets xml_i="8832" xml_f="8842" txt_i="3302" txt_f="3312">Vishamagni</offsets></italic><offsets xml_i="8851" xml_f="8882" txt_i="3312" txt_f="3343">) and obstruction of channels (</offsets><italic><offsets xml_i="8890" xml_f="8904" txt_i="3343" txt_f="3357">Sroto Avarodha</offsets></italic><offsets xml_i="8913" xml_f="8922" txt_i="3357" txt_f="3366">) namely </offsets><italic><offsets xml_i="8930" xml_f="8945" txt_i="3366" txt_f="3381">Annavaha Srotas</offsets></italic><offsets xml_i="8954" xml_f="8984" txt_i="3381" txt_f="3411"> (gastrointestinal tract) and </offsets><italic><offsets xml_i="8992" xml_f="9008" txt_i="3411" txt_f="3427">Pranavaha Srotas</offsets></italic><offsets xml_i="9017" xml_f="9133" txt_i="3427" txt_f="3543"> (respiratory tract) which is manifested as difficulty in swallowing, mouth breathing, choking spells at night, etc.</offsets><xref rid="bib15" ref-type="bibr"><offsets xml_i="9167" xml_f="9169" txt_i="3543" txt_f="3545">15</offsets></xref><offsets xml_i="9176" xml_f="9178" txt_i="3545" txt_f="3547">, </offsets><xref rid="bib16" ref-type="bibr"><offsets xml_i="9212" xml_f="9214" txt_i="3547" txt_f="3549">16</offsets></xref><offsets xml_i="9221" xml_f="9281" txt_i="3549" txt_f="3609"> The present study was conducted to explore the efficacy of </offsets><italic><offsets xml_i="9289" xml_f="9307" txt_i="3609" txt_f="3627">Kumarabharana Rasa</offsets></italic><offsets xml_i="9316" xml_f="9415" txt_i="3627" txt_f="3726"> (KR) in the management of chronic tonsillitis in children. KR has a combined action over vitiated </offsets><italic><offsets xml_i="9423" xml_f="9429" txt_i="3726" txt_f="3732">Doshas</offsets></italic><offsets xml_i="9438" xml_f="9527" txt_i="3732" txt_f="3821"> due to its anti-inflammatory, antimicrobial, immunomodulatory, and rejuvinative effects.</offsets></p></sec><sec id="sec2"><label><offsets xml_i="9559" xml_f="9560" txt_i="3823" txt_f="3824">2</offsets></label><title><offsets xml_i="9575" xml_f="9596" txt_i="3824" txt_f="3845">Materials and methods</offsets></title><sec id="sec2.1"><label><offsets xml_i="9628" xml_f="9631" txt_i="3846" txt_f="3849">2.1</offsets></label><title><offsets xml_i="9646" xml_f="9652" txt_i="3849" txt_f="3855">Design</offsets></title><p><offsets xml_i="9663" xml_f="9746" txt_i="3856" txt_f="3939">This study was an open-labeled double-arm setting with a pre- and post-test design.</offsets></p></sec><sec id="sec2.2"><label><offsets xml_i="9780" xml_f="9783" txt_i="3941" txt_f="3944">2.2</offsets></label><title><offsets xml_i="9798" xml_f="9810" txt_i="3944" txt_f="3956">Participants</offsets></title><p><offsets xml_i="9821" xml_f="9890" txt_i="3957" txt_f="4026">Children presenting with any of the symptoms of chronic tonsillitis (</offsets><italic><offsets xml_i="9898" xml_f="9907" txt_i="4026" txt_f="4035">Tundikeri</offsets></italic><offsets xml_i="9916" xml_f="9925" txt_i="4035" txt_f="4044">), i.e., </offsets><italic><offsets xml_i="9933" xml_f="9947" txt_i="4044" txt_f="4058">Kathina Shotha</offsets></italic><offsets xml_i="9956" xml_f="9983" txt_i="4058" txt_f="4085"> (enlargement of tonsils), </offsets><italic><offsets xml_i="9991" xml_f="9998" txt_i="4085" txt_f="4092">Ragatwa</offsets></italic><offsets xml_i="10007" xml_f="10021" txt_i="4092" txt_f="4106"> (hyperemia), </offsets><italic><offsets xml_i="10029" xml_f="10040" txt_i="4106" txt_f="4117">Galoparodha</offsets></italic><offsets xml_i="10049" xml_f="10063" txt_i="4117" txt_f="4131"> (dysphagia), </offsets><italic><offsets xml_i="10071" xml_f="10088" txt_i="4131" txt_f="4148">Mukha Daurgandhya</offsets></italic><offsets xml_i="10097" xml_f="10111" txt_i="4148" txt_f="4162"> (halitosis), </offsets><italic><offsets xml_i="10119" xml_f="10140" txt_i="4162" txt_f="4183">Lasikagranthi Vriddhi</offsets></italic><offsets xml_i="10149" xml_f="10184" txt_i="4183" txt_f="4218"> (enlargement of lymph nodes), and </offsets><italic><offsets xml_i="10192" xml_f="10197" txt_i="4218" txt_f="4223">Jwara</offsets></italic><offsets xml_i="10206" xml_f="10249" txt_i="4223" txt_f="4266"> (fever) were selected and registered from </offsets><italic><offsets xml_i="10257" xml_f="10271" txt_i="4266" txt_f="4280">Kaumarabhritya</offsets></italic><offsets xml_i="10280" xml_f="11116" txt_i="4280" txt_f="5116"> (Ayurvedic Pediatrics) outpatient department of SDM College of Ayurveda and Hospital, Hassan between June 2012 and December 2013. Before initiating the study ethical clearance was obtained from institutional ethics committee of SDM College of Ayurveda and Hospital, Hassan (IEC No. SDMAH/IEC/57/11-12 dated 01-04-2012). Written informed consent was taken from the parents of the study participants before any study-related procedures were performed. Inclusion criteria were: children of both sexes between 5 and 10 years of age and who had repeated attacks of tonsillitis (chronic infections) in the past year. Exclusion criteria were: patients with acute tonsillitis, peritonsillar abscess, tonsillar cyst, tonsillolith, or any other systemic disorders; patients who had taken systemic steroids and/or antibiotics in the past 4 weeks.</offsets></p></sec><sec id="sec2.3"><label><offsets xml_i="11150" xml_f="11153" txt_i="5118" txt_f="5121">2.3</offsets></label><title><offsets xml_i="11168" xml_f="11179" txt_i="5121" txt_f="5132">Study drugs</offsets></title><sec id="sec2.3.1"><label><offsets xml_i="11213" xml_f="11218" txt_i="5133" txt_f="5138">2.3.1</offsets></label><title><offsets xml_i="11233" xml_f="11251" txt_i="5138" txt_f="5156">Kumarabharana Rasa</offsets></title><p><offsets xml_i="11262" xml_f="11297" txt_i="5157" txt_f="5192">This is a compound drug comprising </offsets><italic><offsets xml_i="11305" xml_f="11312" txt_i="5192" txt_f="5199">Bhasmas</offsets></italic><offsets xml_i="11321" xml_f="11393" txt_i="5199" txt_f="5271"> (purified calx) of Swarna (gold), Rajata (silver), Pravala (coral) and </offsets><italic><offsets xml_i="11401" xml_f="11407" txt_i="5271" txt_f="5277">Churna</offsets></italic><offsets xml_i="11416" xml_f="11441" txt_i="5277" txt_f="5302"> (powder) of Yastimadhu (</offsets><italic><offsets xml_i="11449" xml_f="11467" txt_i="5302" txt_f="5320">Glycyrrhiza glabra</offsets></italic><offsets xml_i="11476" xml_f="11493" txt_i="5320" txt_f="5337"> Linn.), Amlaki (</offsets><italic><offsets xml_i="11501" xml_f="11520" txt_i="5337" txt_f="5356">Emblica officinalis</offsets></italic><offsets xml_i="11529" xml_f="11553" txt_i="5356" txt_f="5380"> Gaertn.), Ashwagandha (</offsets><italic><offsets xml_i="11561" xml_f="11579" txt_i="5380" txt_f="5398">Withania somnifera</offsets></italic><offsets xml_i="11588" xml_f="11606" txt_i="5398" txt_f="5416"> Dunal.), Sunthi (</offsets><italic><offsets xml_i="11614" xml_f="11633" txt_i="5416" txt_f="5435">Zingiber officinale</offsets></italic><offsets xml_i="11642" xml_f="11660" txt_i="5435" txt_f="5453"> Rosc.), Pippali (</offsets><italic><offsets xml_i="11668" xml_f="11680" txt_i="5453" txt_f="5465">Piper longum</offsets></italic><offsets xml_i="11689" xml_f="11708" txt_i="5465" txt_f="5484"> Linn.), Haritaki (</offsets><italic><offsets xml_i="11716" xml_f="11734" txt_i="5484" txt_f="5502">Terminalia chebula</offsets></italic><offsets xml_i="11743" xml_f="11759" txt_i="5502" txt_f="5518"> Retz.), Vacha (</offsets><italic><offsets xml_i="11767" xml_f="11781" txt_i="5518" txt_f="5532">Acorus calamus</offsets></italic><offsets xml_i="11790" xml_f="11835" txt_i="5532" txt_f="5577"> Linn.). All these drugs were processed with </offsets><italic><offsets xml_i="11843" xml_f="11850" txt_i="5577" txt_f="5584">Swarasa</offsets></italic><offsets xml_i="11859" xml_f="11888" txt_i="5584" txt_f="5613"> (extract juice) of Guduchi (</offsets><italic><offsets xml_i="11896" xml_f="11916" txt_i="5613" txt_f="5633">Tinospora cordifolia</offsets></italic><offsets xml_i="11925" xml_f="11966" txt_i="5633" txt_f="5670"> Miers ex Hook. F. &amp; Thoms), Brahmi (</offsets><italic><offsets xml_i="11974" xml_f="11991" txt_i="5670" txt_f="5687">Centella asiatica</offsets></italic><offsets xml_i="12000" xml_f="12020" txt_i="5687" txt_f="5707"> Linn.), and Tulsi (</offsets><italic><offsets xml_i="12028" xml_f="12046" txt_i="5707" txt_f="5725">Ocimum tenuiflorum</offsets></italic><offsets xml_i="12055" xml_f="12103" txt_i="5725" txt_f="5773"> Linn.) separately then prepared in tablet form.</offsets><xref rid="bib17" ref-type="bibr"><sup><offsets xml_i="12142" xml_f="12144" txt_i="5773" txt_f="5775">17</offsets></sup></xref></p></sec><sec id="sec2.3.2"><label><offsets xml_i="12193" xml_f="12198" txt_i="5777" txt_f="5782">2.3.2</offsets></label><title><offsets xml_i="12213" xml_f="12235" txt_i="5782" txt_f="5804">Godhuma Vati (placebo)</offsets></title><p><offsets xml_i="12246" xml_f="12301" txt_i="5805" txt_f="5860">Wheat powder was processed and prepared in tablet form.</offsets></p><p><offsets xml_i="12308" xml_f="12675" txt_i="5861" txt_f="6228">Raw drugs were obtained from SDM Pharmacy, Udupi and authenticated in the Department of Dravyaguna, SDM College of Ayurveda and Hospital, Hassan. The medicine was prepared in the Teaching Pharmacy, SDM College of Ayurveda and Hospital, Hassan. Tablets of 500 mg were prepared and preserved in air-tight, properly labeled plastic bottles containing 30 tablets in each.</offsets></p></sec></sec><sec id="sec2.4"><label><offsets xml_i="12715" xml_f="12718" txt_i="6231" txt_f="6234">2.4</offsets></label><title><offsets xml_i="12733" xml_f="12745" txt_i="6234" txt_f="6246">Intervention</offsets></title><p><offsets xml_i="12756" xml_f="13029" txt_i="6247" txt_f="6520">A total of 53 patients were screened for chronic tonsillitis. Among them 40 patients were enrolled into the study fulfilling the inclusion and exclusion criteria. A convenient sampling technique was adopted, with 20 patients each in study group (KR) and the control group (</offsets><italic><offsets xml_i="13037" xml_f="13049" txt_i="6520" txt_f="6532">Godhuma Vati</offsets></italic><offsets xml_i="13058" xml_f="13224" txt_i="6532" txt_f="6698">). The patients in the study group were treated with KR (tablet form) at a dose of 500 mg once daily for 30 days. The patients in the control group were treated with </offsets><italic><offsets xml_i="13232" xml_f="13244" txt_i="6698" txt_f="6710">Godhuma Vati</offsets></italic><offsets xml_i="13253" xml_f="13408" txt_i="6710" txt_f="6865"> (tablet form) at a dose of 500 mg once daily for 30 days. Parents were advised to crush the tablet to a powder and to give it to the child using honey as </offsets><italic><offsets xml_i="13416" xml_f="13423" txt_i="6865" txt_f="6872">Anupana</offsets></italic><offsets xml_i="13432" xml_f="13512" txt_i="6872" txt_f="6952"> (vehicle for drug administration) before food, in the morning, for both groups.</offsets></p></sec><sec id="sec2.5"><label><offsets xml_i="13546" xml_f="13549" txt_i="6954" txt_f="6957">2.5</offsets></label><title><offsets xml_i="13564" xml_f="13601" txt_i="6957" txt_f="6994">Observation-based assessment criteria</offsets></title><sec id="sec2.5.1"><label><offsets xml_i="13635" xml_f="13640" txt_i="6995" txt_f="7000">2.5.1</offsets></label><title><offsets xml_i="13655" xml_f="13676" txt_i="7000" txt_f="7021">Subjective parameters</offsets></title><p><offsets xml_i="13687" xml_f="13838" txt_i="7022" txt_f="7173">The assessment of the signs and symptoms were done on the Day 0 and Day 31. Severity was assessed by grading 1–5 (absence to severe) for each symptom. </offsets><italic><offsets xml_i="13846" xml_f="13860" txt_i="7173" txt_f="7187">Kathina Shotha</offsets></italic><offsets xml_i="13869" xml_f="14041" txt_i="7187" txt_f="7359"> (enlargement of tonsils) – no enlargement, enlarged within anterior pillars, enlarged within posterior pillars, enlarged beyond pillars, kissing tonsils with sleep apnea. </offsets><italic><offsets xml_i="14049" xml_f="14056" txt_i="7359" txt_f="7366">Ragatwa</offsets></italic><offsets xml_i="14065" xml_f="14238" txt_i="7366" txt_f="7539"> (hyperemia) – no hyperemia, hyperemia of tonsil surface, pinkish appearance of pillars, reddish appearance of surroundings, reddish appearance of surroundings and pharynx. </offsets><italic><offsets xml_i="14246" xml_f="14257" txt_i="7539" txt_f="7550">Galoparodha</offsets></italic><offsets xml_i="14266" xml_f="14486" txt_i="7550" txt_f="7770"> (dysphagia) – no pain while swallowing, pain during swallowing solid food substances, pain during swallowing semi-solid food substances, pain during swallowing liquid food substances, continuous pain/unable to swallow. </offsets><italic><offsets xml_i="14494" xml_f="14511" txt_i="7770" txt_f="7787">Mukha Daurgandhya</offsets></italic><offsets xml_i="14520" xml_f="14782" txt_i="7787" txt_f="8049"> (halitosis) – no halitosis, foul breath experienced by the patient only, foul breath experienced by the patient and friends/parents, foul breath is experienced by a group of surrounding people, foul breath is experienced as soon as the patient opens the mouth. </offsets><italic><offsets xml_i="14790" xml_f="14811" txt_i="8049" txt_f="8070">Lasikagranthi Vriddhi</offsets></italic><offsets xml_i="14820" xml_f="15057" txt_i="8070" txt_f="8307"> (enlargement of lymph nodes) – no palpable lymph nodes, palpable lymph nodes unilateral/warm, palpable lymph nodes bilateral/soft/fluctuant, palpable lymph nodes bilateral which are hard, palpable lymph nodes bilateral with tenderness. </offsets><italic><offsets xml_i="15065" xml_f="15070" txt_i="8307" txt_f="8312">Jwara</offsets></italic><offsets xml_i="15079" xml_f="15163" txt_i="8312" txt_f="8396"> (fever) was measured according in degrees Fahrenheit (normal was 98.6° Fahrenheit).</offsets></p></sec><sec id="sec2.5.2"><label><offsets xml_i="15199" xml_f="15204" txt_i="8398" txt_f="8403">2.5.2</offsets></label><title><offsets xml_i="15219" xml_f="15239" txt_i="8403" txt_f="8423">Objective parameters</offsets></title><p><offsets xml_i="15250" xml_f="15482" txt_i="8424" txt_f="8656">Assessments were based on routine laboratory blood investigations – hemoglobin % (Hb%), total leukocyte count (TLC), neutrophils, lymphocytes, eosinophils, and erythrocyte sedimentation rate (ESR) were performed on Day 0 and Day 31.</offsets></p></sec></sec><sec id="sec2.6"><label><offsets xml_i="15522" xml_f="15525" txt_i="8659" txt_f="8662">2.6</offsets></label><title><offsets xml_i="15540" xml_f="15560" txt_i="8662" txt_f="8682">Statistical analysis</offsets></title><p><offsets xml_i="15571" xml_f="15727" txt_i="8683" txt_f="8839">For the statistical analysis, the Statistical Package for Social Sciences (SPSS) version 16 (SSPS Inc., Chicago. IL, USA) was used. The independent samples </offsets><italic><offsets xml_i="15735" xml_f="15736" txt_i="8839" txt_f="8840">t</offsets></italic><offsets xml_i="15745" xml_f="15768" txt_i="8840" txt_f="8863"> test and Mann-Whitney </offsets><italic><offsets xml_i="15776" xml_f="15777" txt_i="8863" txt_f="8864">U</offsets></italic><offsets xml_i="15786" xml_f="15842" txt_i="8864" txt_f="8920"> test (for between-subjects designs) and paired samples </offsets><italic><offsets xml_i="15850" xml_f="15851" txt_i="8920" txt_f="8921">t</offsets></italic><offsets xml_i="15860" xml_f="15928" txt_i="8921" txt_f="8989"> test and the Wilcoxon test (for within-subjects designs) were done.</offsets></p></sec></sec><sec id="sec3"><label><offsets xml_i="15966" xml_f="15967" txt_i="8992" txt_f="8993">3</offsets></label><title><offsets xml_i="15982" xml_f="15989" txt_i="8993" txt_f="9000">Results</offsets></title><p><offsets xml_i="16000" xml_f="16538" txt_i="9001" txt_f="9539">In present study 40 patients were registered, of which only 37 participants completed the study. The sociodemographic profile of the participants shows that 57.5% (23) were male and the rest 42.5% (17) were females. The age groups of 5–6, 7–8, and 9–10 years consisted of 18 (45%), 27.5% (11), 27.5% (11) participants, respectively. The majority (90%, 36) of the participants belonged to the Hindu religion. Socioeconomic assessment revealed that 37.5% belonged to the lower-middle class followed by 30% in the upper-middle class strata. </offsets><italic><offsets xml_i="16546" xml_f="16554" txt_i="9539" txt_f="9547">Prakriti</offsets></italic><offsets xml_i="16563" xml_f="16628" txt_i="9547" txt_f="9612"> (genetic phenotype) yielded the majority 87.5% (35) were having </offsets><italic><offsets xml_i="16636" xml_f="16656" txt_i="9612" txt_f="9632">Pitta-Kapha Prakriti</offsets></italic><offsets xml_i="16665" xml_f="17375" txt_i="9632" txt_f="10342">. A mixed diet was consumed by 80% (32) of the participants. Sleep patterns showed the 60% (24 participants) slept for around 10 hours/day but 62.5% (25) had disturbed sleep, while 37.5% (15) had normal sleep. The family history of the participants highlighted that 25% (10) had a positive family history of chronic tonsillitis. Duration of tonsillitis revealed that 27.5% (11) participants had a duration of tonsillitis for a period of 3 years or more, 17.5% (7) had a duration of tonsillitis for a period of 2 years or more and 55% (22) had a duration of onset of tonsillitis for a period of 1 year or less. Poor oral hygiene was observed among 67.5% (27) participants and only 10% (4) had good oral hygiene.</offsets></p><p><offsets xml_i="17382" xml_f="18048" txt_i="10343" txt_f="11009">Chief complaints reported were throat pain among 10% (4) patients, difficulty in deglutition in 17.5% (7) patients, halitosis in 12.5% (5) patients, fever in 10% (4) patients, breathing difficulty among 20% (8) patients (16.66%) with complaints of mouth breathing in 22.5% (9) patients. Only 5% (2) reported having Jugulo-digastric lymphadenopathy and 2.5% (1) having enlarged tonsils. Clinical diagnosis revealed 62.5% (25) patients with chronic parenchymatous tonsillitis, 32.5% (13) patients with chronic follicular tonsillitis and only 5% (2) were diagnosed as chronic fibroid tonsillitis. Within the group (Wilcoxon signed ranks test) statistical significance (</offsets><italic><offsets xml_i="18056" xml_f="18057" txt_i="11009" txt_f="11010">p</offsets></italic><offsets xml_i="18066" xml_f="18196" txt_i="11010" txt_f="11137"> &lt; 0.05) on signs and symptoms of chronic tonsillitis was found for KR intervention, but nothing significant was observed with </offsets><italic><offsets xml_i="18204" xml_f="18216" txt_i="11137" txt_f="11149">Godhuma Vati</offsets></italic><offsets xml_i="18225" xml_f="18240" txt_i="11149" txt_f="11164"> intervention (</offsets><xref rid="tbl1" ref-type="table"><offsets xml_i="18274" xml_f="18281" txt_i="11164" txt_f="11171">Table 1</offsets></xref><offsets xml_i="18288" xml_f="18329" txt_i="11171" txt_f="11212">). However, between groups (Mann Whitney </offsets><italic><offsets xml_i="18337" xml_f="18338" txt_i="11212" txt_f="11213">U</offsets></italic><offsets xml_i="18347" xml_f="18447" txt_i="11213" txt_f="11313"> test), the effects of KR on signs and symptoms of chronic tonsillitis was found to be significant (</offsets><italic><offsets xml_i="18455" xml_f="18456" txt_i="11313" txt_f="11314">p</offsets></italic><offsets xml_i="18465" xml_f="18477" txt_i="11314" txt_f="11323"> &lt; 0.05; </offsets><xref rid="tbl2" ref-type="table"><offsets xml_i="18511" xml_f="18518" txt_i="11323" txt_f="11330">Table 2</offsets></xref><offsets xml_i="18525" xml_f="18638" txt_i="11330" txt_f="11443">). Routine laboratory blood investigations assessed within the KR (study group) showed statistical significance (</offsets><italic><offsets xml_i="18646" xml_f="18647" txt_i="11443" txt_f="11444">p</offsets></italic><offsets xml_i="18656" xml_f="18710" txt_i="11444" txt_f="11495"> &lt; 0.05) on Hb%, TLC, lymphocytes and ESR, whereas </offsets><italic><offsets xml_i="18718" xml_f="18730" txt_i="11495" txt_f="11507">Godhuma Vati</offsets></italic><offsets xml_i="18739" xml_f="18771" txt_i="11507" txt_f="11539"> (placebo) were nonsignificant (</offsets><xref rid="tbl3" ref-type="table"><offsets xml_i="18805" xml_f="18812" txt_i="11539" txt_f="11546">Table 3</offsets></xref><offsets xml_i="18819" xml_f="18876" txt_i="11546" txt_f="11603">). The comparisons on the effect of KR (study group) and </offsets><italic><offsets xml_i="18884" xml_f="18896" txt_i="11603" txt_f="11615">Godhuma Vati</offsets></italic><offsets xml_i="18905" xml_f="18982" txt_i="11615" txt_f="11692"> (placebo group) on laboratory investigations and fever were nonsignificant (</offsets><italic><offsets xml_i="18990" xml_f="18991" txt_i="11692" txt_f="11693">p</offsets></italic><offsets xml_i="19000" xml_f="19027" txt_i="11693" txt_f="11717"> &gt; 0.05) as detailed in </offsets><xref rid="tbl4" ref-type="table"><offsets xml_i="19061" xml_f="19068" txt_i="11717" txt_f="11724">Table 4</offsets></xref><offsets xml_i="19075" xml_f="19076" txt_i="11724" txt_f="11725">.</offsets></p></sec><sec id="sec4"><label><offsets xml_i="19108" xml_f="19109" txt_i="11727" txt_f="11728">4</offsets></label><title><offsets xml_i="19124" xml_f="19134" txt_i="11728" txt_f="11738">Discussion</offsets></title><p><offsets xml_i="19145" xml_f="19860" txt_i="11739" txt_f="12454">CHT is an inflammation of the tonsils caused by a microbial infection. The symptoms are usually mild and often related to the common cold. In streptococcal infection the tonsils often swell and become coated and the throat is sore. The patient has a temperature, foul-smelling breath and may feel quite ill. Therefore drugs with anti-inflammatory and immunomodulatory effects may be useful for treatment of CHT. Ayurveda, as well as recent experimental results indicate the ingredients of a poly-herbo-mineral formulation KR as having anti-inflammatory, antimicrobial, and immunomodulatory effects. It is substantiated by the clinical observations among tonsillitis patients. The key ingredients being the metallic </offsets><italic><offsets xml_i="19868" xml_f="19875" txt_i="12454" txt_f="12461">Bhasmas</offsets></italic><offsets xml_i="19884" xml_f="19907" txt_i="12461" txt_f="12484"> (purified calx), like </offsets><italic><offsets xml_i="19915" xml_f="19928" txt_i="12484" txt_f="12497">Swarna Bhasma</offsets></italic><offsets xml_i="19937" xml_f="20007" txt_i="12497" txt_f="12567">, is prepared by incinerating gold processed with herbal preparations.</offsets><xref rid="bib18" ref-type="bibr"><offsets xml_i="20041" xml_f="20043" txt_i="12567" txt_f="12569">18</offsets></xref><offsets xml_i="20050" xml_f="20052" txt_i="12569" txt_f="12571">, </offsets><xref rid="bib19" ref-type="bibr"><offsets xml_i="20086" xml_f="20088" txt_i="12571" txt_f="12573">19</offsets></xref><offsets xml_i="20095" xml_f="20096" txt_i="12573" txt_f="12574">
</offsets><italic><offsets xml_i="20104" xml_f="20117" txt_i="12574" txt_f="12587">Swarna Bhasma</offsets></italic><offsets xml_i="20126" xml_f="20166" txt_i="12587" txt_f="12627"> promotes immunity through phagocytosis.</offsets><xref rid="bib20" ref-type="bibr"><sup><offsets xml_i="20205" xml_f="20207" txt_i="12627" txt_f="12629">20</offsets></sup></xref><offsets xml_i="20220" xml_f="20296" txt_i="12629" txt_f="12705"> Gold poly-herbal formulations are found to increases vitality and immunity.</offsets><xref rid="bib21" ref-type="bibr"><sup><offsets xml_i="20335" xml_f="20337" txt_i="12705" txt_f="12707">21</offsets></sup></xref><offsets xml_i="20350" xml_f="20380" txt_i="12707" txt_f="12737"> The clinical applications of </offsets><italic><offsets xml_i="20388" xml_f="20401" txt_i="12737" txt_f="12750">Swarna Bhasma</offsets></italic><offsets xml_i="20410" xml_f="20512" txt_i="12750" txt_f="12852"> and gold salts in Ayurveda are known for rejuvenation and immunomodulation for some chronic diseases.</offsets><xref rid="bib22" ref-type="bibr"><sup><offsets xml_i="20551" xml_f="20553" txt_i="12852" txt_f="12854">22</offsets></sup></xref><offsets xml_i="20566" xml_f="20642" txt_i="12854" txt_f="12930"> Gold nanoparticles have significant applications in targeted drug delivery.</offsets><xref rid="bib23" ref-type="bibr"><offsets xml_i="20676" xml_f="20678" txt_i="12930" txt_f="12932">23</offsets></xref><offsets xml_i="20685" xml_f="20687" txt_i="12932" txt_f="12934">, </offsets><xref rid="bib24" ref-type="bibr"><offsets xml_i="20721" xml_f="20723" txt_i="12934" txt_f="12936">24</offsets></xref><offsets xml_i="20730" xml_f="20731" txt_i="12936" txt_f="12937">
</offsets><italic><offsets xml_i="20739" xml_f="20752" txt_i="12937" txt_f="12950">Swarna Bhasma</offsets></italic><offsets xml_i="20761" xml_f="20821" txt_i="12950" txt_f="13010"> contains gold particles in the size range of nanoparticles.</offsets><xref rid="bib25" ref-type="bibr"><sup><offsets xml_i="20860" xml_f="20862" txt_i="13010" txt_f="13012">25</offsets></sup></xref><offsets xml_i="20875" xml_f="20902" txt_i="13012" txt_f="13039"> Recent studies shows that </offsets><italic><offsets xml_i="20910" xml_f="20923" txt_i="13039" txt_f="13052">Swarna Bhasma</offsets></italic><offsets xml_i="20932" xml_f="21059" txt_i="13052" txt_f="13179"> contained not only gold, but also several microelements (Fe, Al, Cu, Zn, Co, Mg, Ca, As, Pb, etc.). Animal model studies show </offsets><italic><offsets xml_i="21067" xml_f="21080" txt_i="13179" txt_f="13192">Swarna Bhasma</offsets></italic><offsets xml_i="21089" xml_f="21249" txt_i="13192" txt_f="13352">-treated animals significantly increased superoxide dismutase and catalase activity, which are responsible for reducing free radical concentrations in the body.</offsets><xref rid="bib19" ref-type="bibr"><sup><offsets xml_i="21288" xml_f="21290" txt_i="13352" txt_f="13354">19</offsets></sup></xref><offsets xml_i="21303" xml_f="21330" txt_i="13354" txt_f="13381"> The antioxidant effect of </offsets><italic><offsets xml_i="21338" xml_f="21351" txt_i="13381" txt_f="13394">Swarna Bhasma</offsets></italic><offsets xml_i="21360" xml_f="21463" txt_i="13394" txt_f="13497"> is considered to be one of the mechanisms for the immunomodulatory mode of action of the formulation. </offsets><italic><offsets xml_i="21471" xml_f="21484" txt_i="13497" txt_f="13510">Rajata Bhasma</offsets></italic><offsets xml_i="21493" xml_f="21629" txt_i="13510" txt_f="13646"> (silver calx) is a nanoparticulate complex of silver along with Sn, Cd, Mg, K, Na, S, Ca, P, Si, Al, Cl, Ar, In, Fe, Cu, Ba, Hg, or Cr.</offsets><xref rid="bib26" ref-type="bibr"><sup><offsets xml_i="21668" xml_f="21670" txt_i="13646" txt_f="13648">26</offsets></sup></xref><offsets xml_i="21683" xml_f="21925" txt_i="13648" txt_f="13890"> Recent scientific trends indicate emergence of metallic silver in the form of silver nanoparticles as a potential antimicrobial agent, specially important, as several pathogenic bacteria have developed resistance against various antibiotics.</offsets><xref rid="bib27" ref-type="bibr"><sup><offsets xml_i="21964" xml_f="21966" txt_i="13890" txt_f="13892">27</offsets></sup></xref></p><p><offsets xml_i="21986" xml_f="22018" txt_i="13893" txt_f="13925">Herbal components like Amalaki (</offsets><italic><offsets xml_i="22026" xml_f="22046" txt_i="13925" txt_f="13945">Phylanthus embellica</offsets></italic><offsets xml_i="22055" xml_f="22056" txt_i="13945" txt_f="13946">)</offsets><xref rid="bib28" ref-type="bibr"><offsets xml_i="22090" xml_f="22092" txt_i="13946" txt_f="13948">28</offsets></xref><offsets xml_i="22099" xml_f="22101" txt_i="13948" txt_f="13950">, </offsets><xref rid="bib29" ref-type="bibr"><offsets xml_i="22135" xml_f="22137" txt_i="13950" txt_f="13952">29</offsets></xref><offsets xml_i="22144" xml_f="22158" txt_i="13952" txt_f="13966"> and Guduchi (</offsets><italic><offsets xml_i="22166" xml_f="22186" txt_i="13966" txt_f="13986">Tinospora cordifolia</offsets></italic><offsets xml_i="22195" xml_f="22196" txt_i="13986" txt_f="13987">)</offsets><xref rid="bib30" ref-type="bibr"><sup><offsets xml_i="22235" xml_f="22237" txt_i="13987" txt_f="13989">30</offsets></sup></xref><offsets xml_i="22250" xml_f="22391" txt_i="13989" txt_f="14130"> are having nourishing and rejuvinative property. Experimental studies reveal their immunostimulant activity which combats sepsis in animals.</offsets><xref rid="bib31" ref-type="bibr"><offsets xml_i="22425" xml_f="22427" txt_i="14130" txt_f="14132">31</offsets></xref><offsets xml_i="22434" xml_f="22436" txt_i="14132" txt_f="14134">, </offsets><xref rid="bib32" ref-type="bibr"><offsets xml_i="22470" xml_f="22472" txt_i="14134" txt_f="14136">32</offsets></xref><offsets xml_i="22479" xml_f="22481" txt_i="14136" txt_f="14138">, </offsets><xref rid="bib33" ref-type="bibr"><offsets xml_i="22515" xml_f="22517" txt_i="14138" txt_f="14140">33</offsets></xref><offsets xml_i="22524" xml_f="22526" txt_i="14140" txt_f="14142">, </offsets><xref rid="bib34" ref-type="bibr"><offsets xml_i="22560" xml_f="22562" txt_i="14142" txt_f="14144">34</offsets></xref><offsets xml_i="22569" xml_f="22571" txt_i="14144" txt_f="14146">, </offsets><xref rid="bib35" ref-type="bibr"><offsets xml_i="22605" xml_f="22607" txt_i="14146" txt_f="14148">35</offsets></xref><offsets xml_i="22614" xml_f="22616" txt_i="14148" txt_f="14150">, </offsets><xref rid="bib36" ref-type="bibr"><offsets xml_i="22650" xml_f="22652" txt_i="14150" txt_f="14152">36</offsets></xref><offsets xml_i="22659" xml_f="22768" txt_i="14152" txt_f="14261"> Vacha, Sunthi, Pippali, Ashwagandha, Yastimadhu, Amalaki, and Haritaki all have immunomodulatory properties.</offsets><xref rid="bib37" ref-type="bibr"><offsets xml_i="22802" xml_f="22804" txt_i="14261" txt_f="14263">37</offsets></xref><offsets xml_i="22811" xml_f="22813" txt_i="14263" txt_f="14265">, </offsets><xref rid="bib38" ref-type="bibr"><offsets xml_i="22847" xml_f="22849" txt_i="14265" txt_f="14267">38</offsets></xref><offsets xml_i="22856" xml_f="22858" txt_i="14267" txt_f="14269">, </offsets><xref rid="bib39" ref-type="bibr"><offsets xml_i="22892" xml_f="22894" txt_i="14269" txt_f="14271">39</offsets></xref><offsets xml_i="22901" xml_f="22903" txt_i="14271" txt_f="14273">, </offsets><xref rid="bib40" ref-type="bibr"><offsets xml_i="22937" xml_f="22939" txt_i="14273" txt_f="14275">40</offsets></xref><offsets xml_i="22946" xml_f="23138" txt_i="14275" txt_f="14467"> Pippali is an important drug for the treatment of cough, common cold, and is useful as a digestive. The active principle piperine is known for its bio-enhancing and anti-inflammatory effects.</offsets><xref rid="bib41" ref-type="bibr"><sup><offsets xml_i="23177" xml_f="23179" txt_i="14467" txt_f="14469">41</offsets></sup></xref><offsets xml_i="23192" xml_f="23220" txt_i="14469" txt_f="14497"> Yasthimadhu is a prominent </offsets><italic><offsets xml_i="23228" xml_f="23236" txt_i="14497" txt_f="14505">Rasayana</offsets></italic><offsets xml_i="23245" xml_f="23392" txt_i="14505" txt_f="14652"> known for its immunomodulatory, anti-inflammatory, anti-allergic and antiviral activities. It also enhances permeability in drug delivery systems.</offsets><xref rid="bib42" ref-type="bibr"><sup><offsets xml_i="23431" xml_f="23433" txt_i="14652" txt_f="14654">42</offsets></sup></xref><offsets xml_i="23446" xml_f="23459" txt_i="14654" txt_f="14667"> Yastimadhu (</offsets><italic><offsets xml_i="23467" xml_f="23485" txt_i="14667" txt_f="14685">Glycerrhiza glabra</offsets></italic><offsets xml_i="23494" xml_f="24737" txt_i="14685" txt_f="15928">) also has cytoprotective and demulcent effects and is a popular home remedy for minor throat infections. Biologically active substances in liquorice root include glycyrrhizic acid (GL) and its aglycone (GA), phenolic compounds, oligosaccharides and polysaccharides, lipids, sterine, etc. Many researchers have suggested that the effects on the production of interferon (IFN) and Th2 cytokines might be one of the mechanisms involved in the anti-infective process. Recently, glycyrrhizin has been found to be active in inhibiting replication of the severe acute respiratory syndrome (SARS)-associated virus (FFM-1 and FFM-2) and also H5N1 influenza A virus-infected cells. GL is also reported to have modulatory effects on the complement system. Reports indicate that GL blocks C5 or a more distal stage of the complement cascade, suggesting that it might have a role in preventing tissue injury not only in chronic hepatitis, but also in autoimmune and inflammatory diseases. Chemical modification of GL and GA has been tried, and a significant improvement in anti-inflammatory, antiallergic, and antiulcer activities was observed. These observations indicate immune-modulating and biological response modifier activities associated with GL. </offsets><italic><offsets xml_i="24745" xml_f="24765" txt_i="15928" txt_f="15948">Tinospora cordifolia</offsets></italic><offsets xml_i="24774" xml_f="25417" txt_i="15948" txt_f="16591"> (TC) is known for its immunomodulatory and cytoprotective activities Quaternary alkaloids and biotherapeutic diterpene glucosides of TC (syringin, cordiol, cordioside, and coriofolioside) showed an immunopotentiating activity. Research work has been conducted on berberine, jatrorrhizine, tinosporaside, and columbin, which shows a possible mechanism of immunomodulatory activity as an activation of macrophages, leading to increases in granulocyte–macrophage colony-stimulating factor (GM-CSF), leukocytosis, and improved neutrophil function. TC also inhibits C3 convertase of the classical complement pathway. Research on polysaccharide (α-</offsets><sc><offsets xml_i="25421" xml_f="25422" txt_i="16591" txt_f="16592">d</offsets></sc><offsets xml_i="25427" xml_f="25589" txt_i="16592" txt_f="16754">-glucan) derived from TC shows the activation of nuclear killer (NK) cells, complement system, and Th1 pathway cytokines, coupled with low nitric oxide synthesis.</offsets><xref rid="bib43" ref-type="bibr"><sup><offsets xml_i="25628" xml_f="25630" txt_i="16754" txt_f="16756">43</offsets></sup></xref><offsets xml_i="25643" xml_f="25735" txt_i="16756" txt_f="16848"> Aswagandha has shown promising immunomodulatory effect in inflammatory experimental models.</offsets><xref rid="bib44" ref-type="bibr"><sup><offsets xml_i="25774" xml_f="25776" txt_i="16848" txt_f="16850">44</offsets></sup></xref><offsets xml_i="25789" xml_f="25798" txt_i="16850" txt_f="16859"> Sunthi (</offsets><italic><offsets xml_i="25806" xml_f="25826" txt_i="16859" txt_f="16879">Zingiber officinalis</offsets></italic><offsets xml_i="25835" xml_f="26144" txt_i="16879" txt_f="17188">) has anti-inflammatory property which inhibits LPS-induced NF-κB activation by preventing degradation of the IκB-α, as well as the phosphorylation of ERK1/2, SAPK/JNK, and p38 MAPKs which were associated with a decrease in the expression of inducible nitric oxide synthase (iNOS) and cyclooxyenase-2 (COX-2).</offsets><xref rid="bib45" ref-type="bibr"><sup><offsets xml_i="26183" xml_f="26185" txt_i="17188" txt_f="17190">45</offsets></sup></xref><offsets xml_i="26198" xml_f="26206" txt_i="17190" txt_f="17198"> Vacha (</offsets><italic><offsets xml_i="26214" xml_f="26228" txt_i="17198" txt_f="17212">Acorus calamus</offsets></italic><offsets xml_i="26237" xml_f="26370" txt_i="17212" txt_f="17345">) is reported for its inhibitory effect on mast cell-dependent anaphylactic reactions in allergic reactions of the respiratory tract.</offsets><xref rid="bib46" ref-type="bibr"><sup><offsets xml_i="26409" xml_f="26411" txt_i="17345" txt_f="17347">46</offsets></sup></xref><offsets xml_i="26424" xml_f="26431" txt_i="17347" txt_f="17354"> Amla (</offsets><italic><offsets xml_i="26439" xml_f="26458" txt_i="17354" txt_f="17373">Phyllanthus emblica</offsets></italic><offsets xml_i="26467" xml_f="26654" txt_i="17373" txt_f="17560">) has been reported to suppress the expression of LPS-induced pro-inflammatory genes (COX-2, iNOS, TNF-α, IL-16, and IL-6) in RAW 264.7 murine macrophage cells in a dose-dependent manner.</offsets><xref rid="bib47" ref-type="bibr"><sup><offsets xml_i="26693" xml_f="26695" txt_i="17560" txt_f="17562">47</offsets></sup></xref><offsets xml_i="26708" xml_f="26810" txt_i="17562" txt_f="17664"> Honey is known to enhance the action of these medicines, and has a potential immunomodulatory effect.</offsets><xref rid="bib48" ref-type="bibr"><offsets xml_i="26844" xml_f="26846" txt_i="17664" txt_f="17666">48</offsets></xref><offsets xml_i="26853" xml_f="26855" txt_i="17666" txt_f="17668">, </offsets><xref rid="bib49" ref-type="bibr"><offsets xml_i="26889" xml_f="26891" txt_i="17668" txt_f="17670">49</offsets></xref><offsets xml_i="26898" xml_f="26900" txt_i="17670" txt_f="17672">, </offsets><xref rid="bib50" ref-type="bibr"><offsets xml_i="26934" xml_f="26936" txt_i="17672" txt_f="17674">50</offsets></xref><offsets xml_i="26943" xml_f="26945" txt_i="17674" txt_f="17676">, </offsets><xref rid="bib51" ref-type="bibr"><offsets xml_i="26979" xml_f="26981" txt_i="17676" txt_f="17678">51</offsets></xref></p></sec><sec id="sec5"><label><offsets xml_i="27020" xml_f="27021" txt_i="17680" txt_f="17681">5</offsets></label><title><offsets xml_i="27036" xml_f="27046" txt_i="17681" txt_f="17691">Conclusion</offsets></title><p><offsets xml_i="27057" xml_f="27245" txt_i="17692" txt_f="17880">Thus the poly-herbo-mineral formulation KR has a combined mechanism of action on tonsillitis by reducing the number of attacks. From the Ayurvedic perspective it controls the imbalance of </offsets><italic><offsets xml_i="27253" xml_f="27259" txt_i="17880" txt_f="17886">Doshas</offsets></italic><offsets xml_i="27268" xml_f="27741" txt_i="17886" txt_f="18359"> and thus effectively reduces the signs and symptoms of chronic tonsillitis. However, following the reverse pharmacological perspective we find scientific evidence of its components against inflammation and microbial invasion via multiple mechanisms mostly as immunomodulators, as discussed above. Future studies on KR formulation along the lines of reverse pharmacology may produce more conclusive information about its combined mechanism of action at the molecular level.</offsets></p></sec><sec id="sec6"><title><offsets xml_i="27773" xml_f="27794" txt_i="18361" txt_f="18382">Conflicts of interest</offsets></title><p><offsets xml_i="27805" xml_f="27858" txt_i="18383" txt_f="18436">All authors have no conflicts of interest to declare.</offsets></p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Bohne</surname><given-names>S.</given-names></name><name><surname>Siggel</surname><given-names>R.</given-names></name><name><surname>Sachse</surname><given-names>S.</given-names></name></person-group><article-title>Clinical significance and diagnostic usefulness of serologic markers for improvement of outcome of tonsillectomy in adults with chronic tonsillitis</article-title><source>J Negat Results BioMed</source><volume>12</volume><year>2013</year><fpage>11</fpage><pub-id pub-id-type="pmid">23816317</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Sangar</surname><given-names>B.</given-names></name><name><surname>Genaw</surname><given-names>I.</given-names></name></person-group><article-title>Role of adenotonsillectomy in the quality of life in the children with obstructive sleep apnoea at Al-Khoms hospital, Libya</article-title><source>Int J Otolaryngol Res</source><volume>1</volume><year>2013</year><fpage>31</fpage><lpage>35</lpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="book" id="sref3"><person-group person-group-type="author"><name><surname>Kliegman</surname><given-names>R.M.</given-names></name><name><surname>Behrman</surname><given-names>R.E.</given-names></name><name><surname>Jenson</surname><given-names>H.B.</given-names></name><name><surname>Stanton</surname><given-names>B.F.</given-names></name></person-group><chapter-title>Nelson Textbook of Pediatrics</chapter-title><edition>18th ed.</edition><year>2008</year><publisher-name>Elsevier</publisher-name><publisher-loc>New Delhi</publisher-loc></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>L.J.</given-names></name><name><surname>Hayes</surname><given-names>J.H.</given-names></name><name><surname>Barton</surname><given-names>A.G.</given-names></name><name><surname>Howel</surname><given-names>D.</given-names></name><name><surname>Hawthorne</surname><given-names>M.</given-names></name></person-group><article-title>Impact of clinical practice guidelines on clinicians' behaviour: tonsillectomy in children</article-title><source>J Otolaryngol</source><volume>28</volume><year>1999</year><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">10077780</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>K.</given-names></name><name><surname>Claesson</surname><given-names>R.</given-names></name><name><surname>Perrson</surname><given-names>U.</given-names></name><name><surname>Odegaard</surname><given-names>K.</given-names></name></person-group><article-title>The economic cost of a streptococcal tonsillitis episode</article-title><source>Scand J Prim Health Care</source><volume>13</volume><year>1995</year><fpage>257</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">8693209</pub-id></element-citation></ref><ref id="bib6"><label>6</label><mixed-citation publication-type="other" id="oref1">Tonsillitis [Internet]. <italic>Mayo Clinic</italic>; [updated 2010 May 11; cited 2014 Mar 27]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.mayoclinic.com/health/tonsillitis/DS00273" id="intref0010">http://www.mayoclinic.com/health/tonsillitis/DS00273</ext-link>.</mixed-citation></ref><ref id="bib7"><label>7</label><mixed-citation publication-type="other" id="oref2">Tonsillitis [Internet]. <italic>PubMed Health</italic>; [updated 2011 Nov 7; cited 2014 Mar 27]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002038" id="intref0015">http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002038</ext-link>.</mixed-citation></ref><ref id="bib8"><label>8</label><mixed-citation publication-type="other" id="oref3"><italic>Cleveland Clinic</italic>; [updated 2012 Jul 19; cited 2014 Mar 27]. Available from: <ext-link ext-link-type="uri" xlink:href="http://my.clevelandclinic.org/disorders/tonsillitis_obstructive_sleep_disturbance_pediatric/head_neck_overview.aspx" id="intref0020">http://my.clevelandclinic.org/disorders/tonsillitis_obstructive_sleep_disturbance_pediatric/head_neck_overview.aspx</ext-link>.</mixed-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Surow</surname><given-names>J.B.</given-names></name><name><surname>Handler</surname><given-names>S.D.</given-names></name><name><surname>Telian</surname><given-names>S.A.</given-names></name><name><surname>Fleisher</surname><given-names>G.R.</given-names></name><name><surname>Baranak</surname><given-names>C.C.</given-names></name></person-group><article-title>Bacteriology of tonsil surface and core in children</article-title><source>Laryngoscope</source><volume>99</volume><year>1989</year><fpage>261</fpage><lpage>266</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/sfx_links?ui=1472-6815-5-7%26bibl=B10" id="intref0025">http://www.biomedcentral.com/sfx_links?ui=1472-6815-5-7&amp;bibl=B10</ext-link><pub-id pub-id-type="pmid">2645491</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Gaffney</surname><given-names>R.J.</given-names></name><name><surname>Freeman</surname><given-names>D.J.</given-names></name><name><surname>Walsh</surname><given-names>M.A.</given-names></name><name><surname>Cafferkey</surname><given-names>M.T.</given-names></name></person-group><article-title>Differences in tonsillar core bacteriology in adults and children: a postoperative study of 262 patients</article-title><source>Respir Med</source><volume>85</volume><year>1991</year><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">1759002</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Mitchelmore</surname><given-names>I.J.</given-names></name><name><surname>Reilly</surname><given-names>P.G.</given-names></name><name><surname>Hay</surname><given-names>A.J.</given-names></name><name><surname>Tabaqchali</surname><given-names>S.</given-names></name></person-group><article-title>Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>13</volume><year>1994</year><fpage>542</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">7805681</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name><name><surname>Yokum</surname><given-names>P.</given-names></name><name><surname>Foote</surname><given-names>P.A.</given-names></name></person-group><article-title>Changes in the core tonsillar bacteriology of recurrent tonsillitis: 1977–93</article-title><source>Clin Infect Dis</source><volume>21</volume><year>1995</year><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">7578726</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Stjernquist-Desatnik</surname><given-names>A.</given-names></name><name><surname>Holst</surname><given-names>E.</given-names></name></person-group><article-title>Tonsillar microbial flora: comparison of recurrent tonsillitis and normal tonsils</article-title><source>Acta Otolaryngol (Stockh)</source><volume>119</volume><year>1999</year><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">10219395</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Paradise</surname><given-names>J.L.</given-names></name><name><surname>Bluestone</surname><given-names>C.D.</given-names></name><name><surname>Bachman</surname><given-names>R.Z.</given-names></name></person-group><article-title>Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials</article-title><source>New Engl J Med</source><volume>310</volume><year>1984</year><fpage>674</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">6700642</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="book" id="sref12"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>J.T.</given-names></name></person-group><chapter-title>Sushruta Samhita of Sushruta</chapter-title><edition>1st ed</edition><year>2003</year><publisher-name>Chaukhambha Surbharati Prakashan</publisher-name><publisher-loc>Varanasi</publisher-loc></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="book" id="sref13"><person-group person-group-type="author"><name><surname>Bhisagacharya</surname><given-names>H.P.</given-names></name></person-group><chapter-title>Astanga Hridaya</chapter-title><edition>1st ed.</edition><year>2000</year><publisher-name>Krishnadas Academy</publisher-name><publisher-loc>Varanasi</publisher-loc></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Shailaja</surname><given-names>U.</given-names></name><name><surname>Rao Prasanna</surname><given-names>N.</given-names></name><name><surname>Arun Raj</surname><given-names>G.R.</given-names></name><name><surname>Mallannavar</surname><given-names>V.</given-names></name></person-group><article-title>Effect of Kumarabharana rasa on chronic tonsillitis in children: a pilot clinical study</article-title><source>Int J Res Ayurveda Pharm</source><volume>4</volume><issue>2</issue><year>2013</year><fpage>153</fpage><lpage>157</lpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>P.K.</given-names></name><name><surname>Chaudhary</surname><given-names>A.K.</given-names></name></person-group><article-title>Ayurvedic Bhasma: the most ancient application of nanomedicine</article-title><source>J Sci Industr Res</source><volume>69</volume><year>2010</year><fpage>901</fpage><lpage>915</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>A.</given-names></name><name><surname>Chakraborty</surname><given-names>S.</given-names></name><name><surname>Auddy</surname><given-names>B.</given-names></name></person-group><article-title>Evaluation of chemical constituents and free-radical scavenging activity of Swarna bhasma (gold ash): an Ayurvedic drug</article-title><source>J Ethnopharmacol</source><volume>80</volume><year>2002</year><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">12007704</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Choudhary</surname><given-names>A.</given-names></name></person-group><article-title>Suvarna Bhasma and Gold compounds: an innovation of pharmaceutical illumination of therapeutics</article-title><source>Int J Res Ayurveda Pharm</source><volume>3</volume><year>2012</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Sur</surname><given-names>T.K.</given-names></name><name><surname>Pandit</surname><given-names>S.</given-names></name><name><surname>Mukherjee</surname><given-names>R.</given-names></name><name><surname>Debnath</surname><given-names>P.K.</given-names></name><name><surname>Bandhopadhya</surname><given-names>S.K.</given-names></name><name><surname>Bhattacharya</surname><given-names>D.</given-names></name></person-group><article-title>Effect of Sonachandi Chyawanprash and Chyawanprash Plus, two herbal formulation on Immunomodulation</article-title><source>Nepal Med Coll J</source><volume>6</volume><year>2004</year><fpage>126</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">16295744</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="book" id="sref19"><person-group person-group-type="author"><name><surname>Sastry</surname><given-names>J.L.N.</given-names></name></person-group><chapter-title>Illustrated Dravyaguna Vijnana</chapter-title><edition>2nd ed.</edition><year>2005</year><publisher-name>Chaukhambha Orientalia</publisher-name><publisher-loc>Varanasi</publisher-loc></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Han</surname><given-names>G.</given-names></name><name><surname>De</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>C.K.</given-names></name><name><surname>Rotello</surname><given-names>V.M.</given-names></name></person-group><article-title>Gold nanoparticles in delivery applications</article-title><source>Adv Drug Deliv Rev</source><volume>60</volume><year>2008</year><fpage>1307</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">18555555</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Shipton</surname><given-names>M.K.</given-names></name><name><surname>Ryan</surname><given-names>J.</given-names></name><name><surname>Kaufman</surname><given-names>E.D.</given-names></name><name><surname>Franzen</surname><given-names>S.</given-names></name><name><surname>Feldheim</surname><given-names>D.L.</given-names></name></person-group><article-title>Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide–poly(ethylene glycol) monolayers</article-title><source>Anal Chem</source><volume>79</volume><year>2007</year><fpage>2221</fpage><lpage>2229</lpage><pub-id pub-id-type="pmid">17288407</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>C.L.</given-names></name><name><surname>Bushell</surname><given-names>G.</given-names></name><name><surname>Whitehouse</surname><given-names>M.W.</given-names></name><name><surname>Agrawal</surname><given-names>D.S.</given-names></name><name><surname>Tupe</surname><given-names>S.G.</given-names></name><name><surname>Paknikar</surname><given-names>K.M.</given-names></name></person-group><article-title>Nanogold-pharmaceutics</article-title><source>Gold Bull</source><volume>40</volume><year>2007</year><fpage>245</fpage><lpage>250</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>R.</given-names></name><name><surname>Jha</surname><given-names>C.B.</given-names></name></person-group><article-title>Standard manufacturing procedure of Rajata Bhasma</article-title><source>Ayu</source><volume>32</volume><year>2011</year><fpage>566</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">22661856</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>M.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Gade</surname><given-names>A.</given-names></name></person-group><article-title>Silver nanoparticles as a new generation of antimicrobials</article-title><source>Biotechnol Adv</source><volume>27</volume><year>2009</year><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">18854209</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Sai Ram</surname><given-names>M.</given-names></name><name><surname>Neetu</surname><given-names>D.</given-names></name><name><surname>Yogesh</surname><given-names>B.</given-names></name></person-group><article-title>Cyto-protective and immunomodulating properties of Amla (<italic>Emblica officinalis</italic>) on lymphocytes: an in-vitro study</article-title><source>J Ethnopharmacol</source><volume>81</volume><year>2002</year><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12020921</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Krishnaveni</surname><given-names>M.</given-names></name><name><surname>Mirunalini</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic potential of <italic>Phyllanthus emblica</italic> (amla): the Ayurvedic wonder</article-title><source>J Basic Clin Physiol Pharmacol</source><volume>21</volume><year>2010</year><fpage>93</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">20506691</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Upadhay</surname><given-names>A.K.</given-names></name><name><surname>Kumar</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Mishra</surname><given-names>H.S.</given-names></name></person-group><article-title><italic>Tinospora cordifolia</italic> (Wild) Hook. f and Thoms. (Guduchi) – Validation of the Ayurvedic pharmacology through experimental and clinical studies</article-title><source>Int J Ayurveda Res</source><volume>1</volume><year>2010</year><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">20814526</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Thatte</surname><given-names>U.M.</given-names></name><name><surname>Chabbria</surname><given-names>S.</given-names></name><name><surname>Kanadikar</surname><given-names>S.M.</given-names></name><name><surname>Dhanukar</surname><given-names>S.A.</given-names></name></person-group><article-title>Immunotherapeutic modification of <italic>E. coli</italic> induced abdominal sepsis and mortality in mice by Indian medicinal plants</article-title><source>Indian Drugs</source><volume>25</volume><year>1987</year><fpage>95</fpage><lpage>97</lpage></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Thatte</surname><given-names>U.M.</given-names></name><name><surname>Dhanukar</surname><given-names>S.A.</given-names></name></person-group><article-title>Immune therapeutic modification of experimental infection by Indian medicinal plants</article-title><source>Phytother Res</source><volume>3</volume><year>1983</year><fpage>43</fpage><lpage>49</lpage></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Rege</surname><given-names>N.N.</given-names></name><name><surname>Thatte</surname><given-names>U.M.</given-names></name><name><surname>Dhanukar</surname><given-names>S.A.</given-names></name></person-group><article-title>Adipogenic properties of six rasayana herbs and in Ayurveda medicine</article-title><source>Phytother Res</source><volume>13</volume><year>1999</year><fpage>273</fpage><lpage>291</lpage></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Dhanukar</surname><given-names>S.A.</given-names></name><name><surname>Thatte</surname><given-names>U.M.</given-names></name><name><surname>Pai</surname><given-names>N.</given-names></name><name><surname>More</surname><given-names>P.B.</given-names></name><name><surname>Karardikar</surname><given-names>S.M.</given-names></name></person-group><article-title>Immunotherapeutic modification by <italic>Tinospora cordifolia</italic> of abdominal sepsis induced by coecal ligation in rats</article-title><source>Indian J Gastroenterol</source><volume>7</volume><year>1988</year><fpage>21</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">3338823</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Thatte</surname><given-names>U.M.</given-names></name><name><surname>Kulkarni</surname><given-names>M.R.</given-names></name><name><surname>Dhanukar</surname><given-names>S.A.</given-names></name></person-group><article-title>Immunotherapeutic modification of peritonitis and bacteremia by Tinospora cordifolia</article-title><source>J Postgrad Med</source><volume>36</volume><year>1992</year><fpage>13</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">1512717</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Jayachandra</surname><given-names>R.</given-names></name><name><surname>Xavier</surname><given-names>T.F.</given-names></name><name><surname>Anand</surname><given-names>S.P.</given-names></name></person-group><article-title>Antibacterial activity of stem extract of <italic>Tinospora cordifolia</italic> (Wild)</article-title><source>Anc Sci Life</source><volume>23</volume><year>2003</year><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">22557111</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Patwardhan</surname><given-names>B.</given-names></name><name><surname>Gautam</surname><given-names>M.</given-names></name></person-group><article-title>Botanical immunodrugs: scope and opportunities</article-title><source>Drug Discov Today</source><volume>10</volume><year>2005</year><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">15809195</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Brahma</surname><given-names>S.K.</given-names></name><name><surname>Debnath</surname><given-names>P.K.</given-names></name></person-group><article-title>Therapeutic importance of rasayana drugs with special reference to their multidimensional actions</article-title><source>Aryavaidyan</source><volume>16</volume><year>2003</year><fpage>160</fpage><lpage>163</lpage></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Gulati</surname><given-names>K.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Debnath</surname><given-names>P.K.</given-names></name><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name></person-group><article-title>Immunomodulatory Indian medicinal plants</article-title><source>J Natural Remedies</source><volume>2</volume><year>2002</year><fpage>121</fpage><lpage>131</lpage></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Govindrajan</surname><given-names>R.</given-names></name><name><surname>Vijaykumar</surname><given-names>M.</given-names></name><name><surname>Pushpangadan</surname><given-names>P.</given-names></name></person-group><article-title>Antioxidant approach to disease management and the role of ‘Rasayana’ herbs of Ayurveda</article-title><source>J Ethnopharmacol</source><volume>99</volume><year>2005</year><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">15894123</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Myunk</surname><given-names>J.K.</given-names></name><name><surname>Jae</surname><given-names>Y.C.</given-names></name><name><surname>Byung</surname><given-names>H.S.</given-names></name><name><surname>Duk</surname><given-names>K.K.</given-names></name><name><surname>Jaehwi</surname><given-names>L.</given-names></name></person-group><article-title>Bioavailability enhancing activities of natural compounds from medicinal plants</article-title><source>J Med Plant Res</source><volume>3</volume><year>2009</year><fpage>1204</fpage><lpage>1211</lpage></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S.</given-names></name></person-group><article-title><italic>Glycyrrhiza glabra</italic> – medicine of the millennium</article-title><source>Natural Product Radiance</source><volume>4</volume><year>2005</year><fpage>358</fpage><lpage>367</lpage></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="book" id="sref40"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>P.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Debnath</surname><given-names>P.K.</given-names></name></person-group><chapter-title>Ayurnutrigenomics: traditional knowledge inspired approach towards personalized nutrition</chapter-title><person-group person-group-type="editor"><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Bagchi</surname><given-names>D.</given-names></name><name><surname>Konishi</surname><given-names>T.</given-names></name></person-group><source>Clinical Aspects of Functional Foods and Neutraceuticals</source><year>2014</year><publisher-name>CRC Press</publisher-name><publisher-loc>Florida</publisher-loc><fpage>423</fpage><lpage>444</lpage></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>R.</given-names></name><name><surname>Diwanay</surname><given-names>S.</given-names></name><name><surname>Patki</surname><given-names>P.</given-names></name><name><surname>Patwardhan</surname><given-names>B.</given-names></name></person-group><article-title>Studies on immunomodulatory activity of <italic>Withania somnifera</italic> (Ashwagandha) extracts in experimental immune inflammation</article-title><source>J Ethnopharmacol</source><volume>67</volume><year>1999</year><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10616957</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y.Y.</given-names></name><name><surname>Kim</surname><given-names>M.H.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.-H.H.</given-names></name><name><surname>Yang</surname><given-names>W.M.</given-names></name></person-group><article-title>Dried ginger (<italic>Zingiber officinalis</italic>) inhibits inflammation in a lipopolysaccharide-induced mouse model</article-title><source>Evid Based Complement Alternat Med</source><volume>2013</volume><year>2013</year><fpage>914563</fpage><comment>Epub 2013 Jun 27</comment><pub-id pub-id-type="pmid">23935687</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.-Y.Y.</given-names></name><name><surname>Lee</surname><given-names>S.-H.H.</given-names></name><name><surname>Kim</surname><given-names>W.-J.J.</given-names></name></person-group><article-title>Inhibitory effects of <italic>Acorus calamus</italic> extracts on mast cell-dependent anaphylactic reactions using mast cell and mouse model</article-title><source>J Ethnopharmacol</source><volume>141</volume><year>2012</year><fpage>526</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">22366435</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Sripanidkulchai</surname><given-names>B.</given-names></name><name><surname>Junlatat</surname><given-names>J.</given-names></name></person-group><article-title>Bioactivities of alcohol based extracts of <italic>Phyllanthus emblica</italic> branches: antioxidation, antimelanogenesis and anti-inflammation</article-title><source>J Nat Med</source><volume>68</volume><year>2014</year><fpage>615</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">24557876</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Banarjee</surname><given-names>P.</given-names></name><name><surname>Sahoo</surname><given-names>K.N.</given-names></name><name><surname>Biswas</surname><given-names>T.K.</given-names></name></person-group><article-title>Bees make medicine for mankind</article-title><source>Ind J Tradit Knowl</source><volume>2</volume><issue>1</issue><year>2003</year><fpage>22</fpage><lpage>26</lpage></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>M.D.</given-names></name><name><surname>Mandal</surname><given-names>S.</given-names></name></person-group><article-title>Honey: its medicinal property and antibacterial activity</article-title><source>Asian Pac J Trop Biomed</source><volume>1</volume><year>2011</year><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">23569748</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Majtan</surname><given-names>J.</given-names></name></person-group><article-title>Honey: an immunomodulator in wound healing</article-title><source>Wound Repair Regen</source><volume>22</volume><issue>2</issue><year>2014</year><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">24612472</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Nikaein</surname><given-names>D.</given-names></name><name><surname>Khosravi</surname><given-names>A.</given-names></name><name><surname>Moosavi</surname><given-names>Z.</given-names></name></person-group><article-title>Effect of honey as an immunomodulator against invasive aspergillosis in BALBc mice</article-title><source>J Apicult Res</source><volume>53</volume><year>2014</year><fpage>84</fpage><lpage>90</lpage></element-citation></ref></ref-list><fn-group><fn id="d32e567"><p id="ntpara0010">Peer review under responsibility of The Center for Food and Biomolecules, National Taiwan University.</p></fn></fn-group></back><floats-group><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Effect of <italic>Kumarabharana Rasa</italic> and <italic>Godhuma Vati</italic> on signs and symptoms of chronic tonsillitis (BT &amp; AT) – test statistics within the groups (Wilcoxon signed ranks test).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Sign and symptoms</th><th colspan="2"><italic>Kumarabharana Rasa</italic><hr></hr></th><th colspan="2"><italic>Godhuma Vati</italic><hr></hr></th></tr><tr><th><italic>Z</italic></th><th><italic>P</italic> (2-tailed)</th><th><italic>Z</italic></th><th><italic>P</italic> (2-tailed)</th></tr></thead><tbody><tr><td><italic>Kathina Shotha</italic> (enlargement of tonsils)</td><td align="char">−3.100</td><td align="char">0.002</td><td align="char">−1.414</td><td align="char">0.157</td></tr><tr><td><italic>Ragatwa</italic> (hyperemia)</td><td align="char">−3.256</td><td align="char">0.001</td><td align="char">−1.890</td><td align="char">0.059</td></tr><tr><td><italic>Galoparodha</italic> (dysphagia)</td><td align="char">−3.580</td><td align="char">0.000</td><td align="char">−0.378</td><td align="char">0.705</td></tr><tr><td><italic>Mukha Daurgandhya</italic> (halitosis)</td><td align="char">−3.341</td><td align="char">0.001</td><td align="char">0.000</td><td align="char">1.000</td></tr><tr><td><italic>Lasikagranthi Vriddhi</italic> (enlargement of lymph nodes)</td><td align="char">−3.473</td><td align="char">0.001</td><td align="char">−1.633</td><td align="char">0.102</td></tr></tbody></table></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Comparison on the effect of <italic>Kumarabharana Rasa</italic> (study group) and <italic>Godhuma Vati</italic> (placebo group) on signs and symptoms – test statistics<xref rid="tbl2fnb" ref-type="table-fn">b</xref> between the groups (Mann Whitney <italic>U</italic> test).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>BT &amp; AT</th><th><italic>Kathina Shotha</italic> (enlargement of tonsils)</th><th><italic>Ragatwa</italic> (hyperemia)</th><th><italic>Galoparodha</italic> (dysphagia)</th><th><italic>Mukha Daurgandhya</italic> (halitosis)</th><th><italic>Lasikagranthi Vriddhi</italic> (enlargement of lymph nodes)</th></tr></thead><tbody><tr><td>Mann-Whitney <italic>U</italic></td><td align="char">60.000</td><td align="char">101.500</td><td align="char">50.000</td><td align="char">54.000</td><td align="char">65.500</td></tr><tr><td>Wilcoxon <italic>W</italic></td><td align="char">213.000</td><td align="char">254.500</td><td align="char">203.000</td><td align="char">207.000</td><td align="char">218.500</td></tr><tr><td><italic>Z</italic></td><td align="char">−3.856</td><td align="char">−2.335</td><td align="char">−3.910</td><td align="char">−3.932</td><td align="char">−3.465</td></tr><tr><td>Asymp. Sig. (2-tailed)</td><td align="char">0.000</td><td align="char">0.020</td><td align="char">0.000</td><td align="char">0.000</td><td align="char">0.001</td></tr><tr><td>Exact Sig. [2*(1-tailed Sig.)]</td><td align="char">0.001<xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td align="char">0.036<xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td align="char">0.000<xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td align="char">0.000<xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td align="char">0.001<xref rid="tbl2fna" ref-type="table-fn">a</xref></td></tr></tbody></table><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0015">Not corrected for ties.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnb"><label>b</label><p id="ntpara0020">Grouping variable: group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p><italic>Kumarabharana Rasa</italic> and <italic>Godhuma Vati</italic> on laboratory investigations and fever in chronic tonsillitis (BT &amp; AT) – paired samples test (within group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Parameters</th><th colspan="4"><italic>Kumarabharana Rasa</italic><hr></hr></th><th colspan="4"><italic>Godhuma Vati</italic><hr></hr></th></tr><tr><th>Mean difference</th><th>Std. deviation</th><th>Std. error mean</th><th><italic>p</italic></th><th>Mean difference</th><th>Std. deviation</th><th>Std. error mean</th><th><italic>p</italic></th></tr></thead><tbody><tr><td>Hb%</td><td align="char">−0.34000</td><td align="char">0.69008</td><td align="char">0.15431</td><td align="char">0.040</td><td align="char">−0.16471</td><td align="char">.86092</td><td align="char">.20880</td><td align="char">0.442</td></tr><tr><td>TLC</td><td align="char">1.83700</td><td align="char">3174.19878</td><td align="char">709.77242</td><td align="char">0.018</td><td align="char">5.35294</td><td align="char">2708.9991</td><td align="char">657.02881</td><td align="char">0.427</td></tr><tr><td>Neutrophils</td><td align="char">4.00000</td><td align="char">9.48683</td><td align="char">2.12132</td><td align="char">0.075</td><td align="char">0.58824</td><td align="char">7.53375</td><td align="char">1.82720</td><td align="char">0.752</td></tr><tr><td>Lymphocytes</td><td align="char">4.30000</td><td align="char">8.54770</td><td align="char">1.91132</td><td align="char">0.037</td><td align="char">−3.35294</td><td align="char">7.38191</td><td align="char">1.79038</td><td align="char">0.079</td></tr><tr><td>Eosinophils</td><td align="char">0.40000</td><td align="char">1.14248</td><td align="char">0.25547</td><td align="char">0.134</td><td align="char">0.70588</td><td align="char">1.53153</td><td align="char">0.37145</td><td align="char">0.076</td></tr><tr><td>ESR</td><td align="char">1.08000</td><td align="char">16.80413</td><td align="char">3.75752</td><td align="char">0.010</td><td align="char">1.64706</td><td align="char">10.32558</td><td align="char">2.50432</td><td align="char">0.520</td></tr><tr><td>Temperature</td><td align="char">0.39500</td><td align="char">0.87327</td><td align="char">0.19527</td><td align="char">0.057</td><td align="char">−0.08235</td><td align="char">2.47897</td><td align="char">0.60124</td><td align="char">0.893</td></tr></tbody></table></table-wrap><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><p>Comparison on the effect of <italic>Kumarabharana Rasa</italic> (study group) and <italic>Godhuma Vati</italic> (placebo group) on laboratory investigations and fever – independent samples test (between groups).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Differences BT &amp; AT</th><th><italic>t</italic></th><th>Sig. 2-tailed (<italic>p</italic>)</th><th>Mean diff.</th><th>Std. error diff.</th></tr></thead><tbody><tr><td>Hb%</td><td align="char">−0.688</td><td align="char">0.496</td><td align="char">−0.17529</td><td align="char">0.25496</td></tr><tr><td>TLC</td><td align="char">1.328</td><td align="char">0.193</td><td align="char">1301.70588</td><td align="char">979.95025</td></tr><tr><td>Neutrophils</td><td align="char">1.560</td><td align="char">0.128</td><td align="char">4.31176</td><td align="char">2.76446</td></tr><tr><td>Lymphocytes</td><td align="char">−0.357</td><td align="char">0.723</td><td align="char">−0.94706</td><td align="char">2.65088</td></tr><tr><td>Eosinophils</td><td align="char">−0.695</td><td align="char">0.492</td><td align="char">−0.30588</td><td align="char">0.44022</td></tr><tr><td>ESR</td><td align="char">1.952</td><td align="char">0.059</td><td align="char">9.15294</td><td align="char">4.68889</td></tr><tr><td>Temperature</td><td align="char">0.778</td><td align="char">0.442</td><td align="char">0.46088</td><td align="char">0.59237</td></tr></tbody></table></table-wrap></floats-group></article>